174 related articles for article (PubMed ID: 19242111)
1. Total ERK1/2 activity regulates cell proliferation.
Lefloch R; Pouysségur J; Lenormand P
Cell Cycle; 2009 Mar; 8(5):705-11. PubMed ID: 19242111
[TBL] [Abstract][Full Text] [Related]
2. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels.
Lefloch R; Pouysségur J; Lenormand P
Mol Cell Biol; 2008 Jan; 28(1):511-27. PubMed ID: 17967895
[TBL] [Abstract][Full Text] [Related]
3. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
Hong SK; Yoon S; Moelling C; Arthan D; Park JI
J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
[TBL] [Abstract][Full Text] [Related]
4. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
5. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.
Vantaggiato C; Formentini I; Bondanza A; Bonini C; Naldini L; Brambilla R
J Biol; 2006; 5(5):14. PubMed ID: 16805921
[TBL] [Abstract][Full Text] [Related]
6. A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.
Hong SK; Wu PK; Park JI
Cell Signal; 2018 Jan; 42():11-20. PubMed ID: 28986121
[TBL] [Abstract][Full Text] [Related]
7. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.
Voisin L; Saba-El-Leil MK; Julien C; Frémin C; Meloche S
Mol Cell Biol; 2010 Jun; 30(12):2918-32. PubMed ID: 20368360
[TBL] [Abstract][Full Text] [Related]
8. ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1.
Buscà R; Christen R; Lovern M; Clifford AM; Yue JX; Goss GG; Pouysségur J; Lenormand P
BMC Evol Biol; 2015 Sep; 15():179. PubMed ID: 26336084
[TBL] [Abstract][Full Text] [Related]
9. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.
Bae D; Ceryak S
Biochem Biophys Res Commun; 2009 Aug; 385(4):523-7. PubMed ID: 19465001
[TBL] [Abstract][Full Text] [Related]
10. Analysis of isoform specific ERK signaling on the effects of interleukin-1β on COX-2 expression and PGE2 production in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Biochem Biophys Res Commun; 2010 Nov; 402(1):23-9. PubMed ID: 20883667
[TBL] [Abstract][Full Text] [Related]
11. Association of upregulated Ras/Raf/ERK1/2 signaling with autism.
Zou H; Yu Y; Sheikh AM; Malik M; Yang K; Wen G; Chadman KK; Brown WT; Li X
Genes Brain Behav; 2011 Jul; 10(5):615-24. PubMed ID: 21595826
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
13. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication.
Zhu M; Duan H; Gao M; Zhang H; Peng Y
Viruses; 2015 Mar; 7(3):1344-56. PubMed ID: 25803100
[TBL] [Abstract][Full Text] [Related]
14. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.
Kim JH; Hong SK; Wu PK; Richards AL; Jackson WT; Park JI
Exp Cell Res; 2014 Oct; 327(2):340-52. PubMed ID: 25128814
[TBL] [Abstract][Full Text] [Related]
15. Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2.
Frémin C; Bessard A; Ezan F; Gailhouste L; Régeard M; Le Seyec J; Gilot D; Pagès G; Pouysségur J; Langouët S; Baffet G
Hepatology; 2009 Mar; 49(3):930-9. PubMed ID: 19177593
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
17. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
18. Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.
Frémin C; Saba-El-Leil MK; Lévesque K; Ang SL; Meloche S
Cell Rep; 2015 Aug; 12(6):913-21. PubMed ID: 26235619
[TBL] [Abstract][Full Text] [Related]
19. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.
Shin S; Dimitri CA; Yoon SO; Dowdle W; Blenis J
Mol Cell; 2010 Apr; 38(1):114-27. PubMed ID: 20385094
[TBL] [Abstract][Full Text] [Related]
20. ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation.
Wei F; Xie Y; He L; Tao L; Tang D
Cell Signal; 2011 Jan; 23(1):259-68. PubMed ID: 20840867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
